A G Papavassiliou

Author PubWeight™ 44.91‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cell proteins bind to multiple sites within the 5' untranslated region of poliovirus RNA. Proc Natl Acad Sci U S A 1989 2.65
2 Retracted Renaturation of denatured lambda repressor requires heat shock proteins. Cell 1990 2.05
3 Oncogene-induced replication stress preferentially targets common fragile sites in preneoplastic lesions. A genome-wide study. Oncogene 2007 1.85
4 Identification of a promoter mapping within the reiterated sequences that flank the herpes simplex virus type 1 UL region. J Virol 1993 1.77
5 Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation. Eur J Cancer 2003 1.65
6 Analysis of the herpes simplex virus type 1 promoter controlling the expression of UL38, a true late gene involved in capsid assembly. J Virol 1991 1.54
7 Activation of the JNK-AP-1 signal transduction pathway is associated with pathogenesis and progression of human osteosarcomas. Bone 2003 1.14
8 Serine phosphorylation of insulin receptor substrate-1: a novel target for the reversal of insulin resistance. Mol Endocrinol 2001 1.10
9 Phosphorylation of Drosophila Jun by the MAP kinase rolled regulates photoreceptor differentiation. EMBO J 1996 1.05
10 Expression of the 27-kDa heat shock protein (HSP27) in gastric carcinomas and adjacent normal, metaplastic, and dysplastic gastric mucosa, and its prognostic significance. J Cancer Res Clin Oncol 2002 1.03
11 Selective uptake and degradation of c-Fos and v-Fos by rat liver lysosomes. FEBS Lett 1996 0.99
12 Androgen receptor (AR) expression is an independent unfavorable prognostic factor in gastric cancer. J Cancer Res Clin Oncol 2004 0.99
13 Biochemistry versus molecular medicine: what should we be teaching our medical students? Mol Med Today 1999 0.96
14 The MAPK-AP-1/-Runx2 signalling axes are implicated in chondrosarcoma pathobiology either independently or via up-regulation of VEGF. Histopathology 2005 0.96
15 EGFR, HER-2 and COX-2 levels in colorectal cancer. Histopathology 2008 0.94
16 Mining microarray data to identify transcription factors expressed in naïve resting but not activated T lymphocytes. Genes Immun 2004 0.90
17 Flavonoids in atherosclerosis: an overview of their mechanisms of action. Curr Med Chem 2013 0.90
18 Stretch-mediated activation of selective MAPK subtypes and potentiation of AP-1 binding in human osteoblastic cells. Mol Med 2001 0.88
19 Adiponectin and cardiovascular disease: mechanisms and new therapeutic approaches. Curr Med Chem 2012 0.87
20 Transactivation by herpes simplex virus proteins ICP4 and ICP0 in vaccinia virus infected cells. Virology 1991 0.87
21 Novel biological agents for the treatment of hormone-refractory prostate cancer (HRPC). Curr Med Chem 2005 0.86
22 Single-step piperidine elution, cleavage, and recovery of premodified DNA electrotransferred on NA-45 membrane from mobility-shift gels. Nucleic Acids Res 1993 0.85
23 Molecular 'palpation' of BPH: a tale of MAPK signalling? Trends Mol Med 2001 0.85
24 Different TRE-related elements are distinguished by sets of DNA-binding proteins with overlapping sequence specificity. Nucleic Acids Res 1993 0.84
25 Absence of association with cancer risk and low frequency of alterations at a p53 responsive PIG3 gene polymorphism in breast and lung carcinomas. Mutat Res 2004 0.84
26 DNA repair mechanisms in colorectal carcinogenesis. Curr Mol Med 2012 0.82
27 Peripheral targets in obesity treatment: a comprehensive update. Obes Rev 2014 0.82
28 ERp29 regulates response to doxorubicin by a PERK-mediated mechanism. Biochim Biophys Acta 2011 0.81
29 Structure and regulation of the growth arrest-specific (gas-1) promoter. J Biol Chem 1993 0.80
30 Mechanical stress induces DNA synthesis in PDL fibroblasts by a mechanism unrelated to autocrine growth factor action. FEBS Lett 1998 0.80
31 Low levels of p27 in association with deregulated p53-pRb protein status enhance tumor proliferation and chromosomal instability in non-small cell lung carcinomas. Mol Med 2001 0.80
32 Intriguing issues of EGFR targeting in head and neck cancer. Ann Oncol 2007 0.79
33 Rab and rho GTPases are involved in specific response of periodontal ligament fibroblasts to mechanical stretching. Biochim Biophys Acta 1995 0.79
34 Retraction: renaturation of denatured lambda repressor requires heat shock proteins. Cell 1992 0.78
35 Prostate cancer: horizons in the development of novel anti-cancer strategies. Curr Med Chem Anticancer Agents 2001 0.77
36 A coupled Southwestern--DNase I footprinting assay. Nucleic Acids Res 1992 0.77
37 Novel biomarkers assessing the calcium deposition in coronary artery disease. Curr Med Chem 2012 0.77
38 Biomarkers determining cardiovascular risk in patients with kidney disease. Curr Med Chem 2012 0.77
39 Induction of the CBP transcriptional co-activator early during laryngeal carcinogenesis. J Cancer Res Clin Oncol 2002 0.77
40 Atypical induction of the unfolded protein response by mifepristone. Endocrine 2010 0.77
41 Relationship of the K-ras/c-mos expression patterns with angiogenesis in non-small cell lung carcinomas. Mol Med 2001 0.76
42 p53-Targeted drugs: intelligent weapons in the tumor-suppressing arsenal. J Cancer Res Clin Oncol 2000 0.76
43 ErbB/HER receptor family in breast cancer--the more we search the more we learn. Ann Oncol 2008 0.76
44 Mechanical loading triggers specific biochemical responses in mandibular condylar chondrocytes. Biochim Biophys Acta 1994 0.76
45 Distinguishing specific from nonspecific complexes on southwestern blots by a rapid DMS protection assay. Nucleic Acids Res 1993 0.75
46 Compartmentalisation of EGFR signalling might potentiate the optimal use of EGFR tyrosine kinase inhibitors in cancer therapeutics. Br J Cancer 2007 0.75
47 Differential expression of retinoic acid receptor beta (RARbeta) and the AP-1 transcription factor in normal, premalignant and malignant human laryngeal tissues. Eur J Cancer 2004 0.75
48 The therapeutic potential of targeting drugs at transcription factors. Expert Opin Investig Drugs 1999 0.75
49 Predictive value of biomarkers in patients with heart failure. Curr Med Chem 2012 0.75
50 Type 2 diabetes mellitus and worm longevity: a transcriptional link to cure? Trends Endocrinol Metab 2001 0.75
51 Molecular pathogenesis of non muscle-invasive bladder cancer: implications for novel targeted therapies. Curr Mol Med 2011 0.75
52 Circulating biomarkers for the diagnosis and prognosis of heart failure. Curr Med Chem 2009 0.75
53 Molecular "rehabilitation" by rational drug targeting: the challenge of P53 in cancer treatment. Anticancer Res 2000 0.75